BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19483725)

  • 1. Anchorage-independent cell growth signature identifies tumors with metastatic potential.
    Mori S; Chang JT; Andrechek ER; Matsumura N; Baba T; Yao G; Kim JW; Gatza M; Murphy S; Nevins JR
    Oncogene; 2009 Aug; 28(31):2796-805. PubMed ID: 19483725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
    Bild AH; Yao G; Chang JT; Wang Q; Potti A; Chasse D; Joshi MB; Harpole D; Lancaster JM; Berchuck A; Olson JA; Marks JR; Dressman HK; West M; Nevins JR
    Nature; 2006 Jan; 439(7074):353-7. PubMed ID: 16273092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.
    Glinsky GV; Berezovska O; Glinskii AB
    J Clin Invest; 2005 Jun; 115(6):1503-21. PubMed ID: 15931389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
    Bild AH; Parker JS; Gustafson AM; Acharya CR; Hoadley KA; Anders C; Marcom PK; Carey LA; Potti A; Nevins JR; Perou CM
    Breast Cancer Res; 2009; 11(4):R55. PubMed ID: 19638211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
    Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
    Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional profiling: from microarrays via cell-based assays to novel tumor relevant modulators of the cell cycle.
    Arlt D; Huber W; Liebel U; Schmidt C; Majety M; Sauermann M; Rosenfelder H; Bechtel S; Mehrle A; Bannasch D; Schupp I; Seiler M; Simpson JC; Hahne F; Moosmayer P; Ruschhaupt M; Guilleaume B; Wellenreuther R; Pepperkok R; Sültmann H; Poustka A; Wiemann S
    Cancer Res; 2005 Sep; 65(17):7733-42. PubMed ID: 16140941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
    Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
    BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
    Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
    Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.
    Davis-Marcisak EF; Fitzgerald AA; Kessler MD; Danilova L; Jaffee EM; Zaidi N; Weiner LM; Fertig EJ
    Genome Med; 2021 Aug; 13(1):129. PubMed ID: 34376232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.
    Shen R; Ghosh D; Chinnaiyan AM
    BMC Genomics; 2004 Dec; 5(1):94. PubMed ID: 15598354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.
    Thomsen KG; Terp MG; Lund RR; Søkilde R; Elias D; Bak M; Litman T; Beck HC; Lyng MB; Ditzel HJ
    Oncotarget; 2015 Oct; 6(30):29224-39. PubMed ID: 26317550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential.
    Andrechek ER; Cardiff RD; Chang JT; Gatza ML; Acharya CR; Potti A; Nevins JR
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16387-92. PubMed ID: 19805309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis.
    Itzel T; Scholz P; Maass T; Krupp M; Marquardt JU; Strand S; Becker D; Staib F; Binder H; Roessler S; Wang XW; Thorgeirsson S; Müller M; Galle PR; Teufel A
    Bioinformatics; 2015 Jan; 31(2):216-24. PubMed ID: 25236463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
    Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a stem cell-based signature to guide therapeutic selection in cancer.
    Shats I; Gatza ML; Chang JT; Mori S; Wang J; Rich J; Nevins JR
    Cancer Res; 2011 Mar; 71(5):1772-80. PubMed ID: 21169407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards elucidation of functional molecular signatures of the adhesive-migratory phenotype of malignant cells.
    Geiger T; Geiger B
    Semin Cancer Biol; 2010 Jun; 20(3):146-52. PubMed ID: 20493263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers.
    Yu K; Ganesan K; Tan LK; Laban M; Wu J; Zhao XD; Li H; Leung CH; Zhu Y; Wei CL; Hooi SC; Miller L; Tan P
    PLoS Genet; 2008 Jul; 4(7):e1000129. PubMed ID: 18636107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.